Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.604, 2010-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemfibrozil warranted for primary prevention of CHD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 473, 2005-01 ,pp. :
Access to resources
Recommend
Gemfibrozil warranted for primary prevention of CHD
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
Neonatal group B streptococcal sepsis prevention worthwhile
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Aspirin worthwhile as primary CVD prevention in hypertension
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
Oral rivaroxaban a worthwhile choice for VTE prevention in US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :